Additionally, various anabolic processes within the skeletal muscle are aided by insulin-like growth factor-1 (IGF-1), while low IGF-1 concentrations are related to skeletal muscle atrophy, suggesting that it could possibly be a key component in the development of sarcopenia [41]. The gene discussed is IGF1; the disease is sarcopenia.